NORTH CHICAGO, Ill., July 9, 2020 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental Biologics License ...
Botulinum toxin type A (BTXA) has emerged as a promising alternative to traditional incisional surgery in correcting strabismus, a condition characterised by misalignment of the eyes. By temporarily ...
NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA (BOTOX®) ...
NORTH CHICAGO, Ill., Feb. 10, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved BOTOX® for the treatment of ...
Botulinum toxin (BoNT), often referred to as a “miracle poison,” is one of the deadliest biological substances known to man. 1 BoNT is a neurotoxin produced by Clostridium botulinum. A rod-shaped ...
Strabismus eye conditions, often referred to as crossed eyes or crooked eyes, can be classified in several ways depending on their appearance and frequency. Among the common strabismus types based on ...